FibroBiologics, Inc. Common Stock (NASDAQ: FBLG) — Healthcare · Share Price, Chart & Market Data
About: FibroBiologics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of fibroblast-based therapies for patients suffering from chronic diseases. The company's product pipeline includes CYWC628 which has completed pre-clinical trial for the treatment of wound healing; CYMS101 which has completed Phase 1 trial for the treatment of multiple sclerosis; CybroCell for the treatment of degenerative disc disease; and CYPS317 for the treatment of psoriasis. It also develops early-stage research products, including CYTER915 to treat the human longevity; and TCB190 for the treatment of certain cancers. FibroBiologics, Inc. was incorporated in 2021 and is headquartered in Houston, Texas.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.42 (-5.96%)
FBLGFibroBiologics, Inc. Common Stock
Loading watchlist status…
Trade FBLG now
FibroBiologics, Inc. Common Stock share price
FBLG price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 10:44 am GMT+0
FBLG price performance
-6.579%
5D
-63.886%
1M
-70.417%
YTD
-93.744%
1Y
FBLG price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 10:44 am GMT+0
FBLG details
FBLG Market Signals